| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,323,049 |
| 52
Week Range: |
$0.937 - $1.235 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-12-20 |
5 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
57,177 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-12-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
1,484,106 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-12-19 |
4 |
D |
$11.34 |
$53,298 |
D/D |
(4,700) |
7,550 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-12-19 |
4 |
A |
$11.34 |
$113,400 |
D/D |
10,000 |
12,250 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-12-19 |
4 |
D |
$11.34 |
$167,016 |
D/D |
(14,728) |
2,407,829 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-12-19 |
4 |
A |
$11.34 |
$1,849,996 |
D/D |
163,139 |
2,422,557 |
|
- |
|
| Arora Krishan K |
Director |
– • – |
2012-12-19 |
4 |
A |
$11.34 |
$113,400 |
D/D |
10,000 |
15,000 |
|
- |
|
| Gagnon Gilles |
Director |
– • – |
2012-12-19 |
4 |
A |
$11.34 |
$113,400 |
D/D |
10,000 |
35,000 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2012-12-19 |
4 |
A |
$11.34 |
$113,400 |
D/D |
10,000 |
10,000 |
|
- |
|
| Gueth Anton |
Director |
– • – |
2012-12-19 |
4 |
A |
$11.34 |
$113,400 |
D/D |
10,000 |
11,000 |
|
- |
|
| Lenaz Luigi Md |
Director |
– • – |
2012-12-19 |
4 |
D |
$11.34 |
$31,752 |
D/D |
(2,800) |
29,077 |
|
- |
|
| Lenaz Luigi Md |
Director |
– • – |
2012-12-19 |
4 |
A |
$11.34 |
$113,400 |
D/D |
10,000 |
31,877 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-12-18 |
5 |
GA |
$0.00 |
$0 |
I/I |
912,185 |
10,676 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
466,192 |
1,484,106 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • • |
2012-12-18 |
5 |
GD |
$0.00 |
$0 |
I/I |
445,993 |
9,523 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-12-04 |
4 |
AS |
$11.65 |
$58,265 |
D/D |
(5,000) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-12-04 |
4 |
OE |
$4.26 |
$21,300 |
D/D |
5,000 |
7,250 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-11-29 |
4 |
D |
$11.20 |
$612,360 |
D/D |
(54,675) |
2,262,241 |
|
- |
|
| Keller Joseph Kenneth |
EVP & Chief Operating Officer |
• – – |
2012-11-12 |
4 |
B |
$10.95 |
$109,469 |
D/D |
10,000 |
138,000 |
2.74 |
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-11-01 |
4 |
AS |
$11.07 |
$55,439 |
D/D |
(5,000) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-11-01 |
4 |
OE |
$2.55 |
$15,657 |
D/D |
5,000 |
3,950 |
|
- |
|
| Shrotriya Rajesh C Md |
Chairman, CEO & President |
• • – |
2012-10-09 |
4 |
AS |
$12.50 |
$141,875 |
D/D |
(11,350) |
2,316,916 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-10-02 |
4 |
AS |
$11.80 |
$59,009 |
D/D |
(5,000) |
2,250 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2012-10-02 |
4 |
OE |
$6.65 |
$33,250 |
D/D |
5,000 |
7,250 |
|
- |
|
| Scott Brett L |
Acting Chief Financial Officer |
• – – |
2012-10-01 |
4 |
AS |
$12.00 |
$72,000 |
D/D |
(6,000) |
45,661 |
|
- |
|
658 Records found
|
|
Page 21 of 27 |
|
|
